Cemiplimab With Fianlimab for Resectable Non-Metastatic Colon Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Cemiplimab With Fianlimab for Resectable Non-Metastatic Colon Cancer	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, malignant colon neoplasm, neoplasm	Not yet recruiting	Phase 2	2026-08-27		NCT07224022

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
John Strickler, M.D.	1
Regeneron Pharmaceuticals	238

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials